Connect with us


Recon: Gilead to buy Immunomedics for $ 21B; Trump signs international reference price order



Posted on September 14, 2020 | from Michael Mezher

Recon: Gilead to buy Immunomedics for $ 21B;  Trump signs international reference price order

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.

In focus: USA

  • Trump unveils plan to cut drug-related drug costs abroad (Politico) (NYTimes) (WSJ) (COUNTRY)
  • Trump pushed for plasma therapy. Officials worry, is it further a yellowingless vaccine? (NYTimes)
  • Gilead reaches deal to buy immunomedicine for $ 21 billion (WSJ) (FT) (Reuters) (COUNTRY)
  • Merck to buy $ 1 billion stake in Seattle Genetics, co-development of cancer therapy (Reuters)
  • Trump officials intervene in CDC reports on Covid-19 (Politico)
  • US Employers Cut Out $ 6 Billion in Vain Drug Eyes (Bloomberg)
  • The Kodak Agreement draws review from the observer to the agency involved in the planned loan (WSJ)
  • Pfizer and BioNTech announce plan to extend Covid-19 vaccine trial (COUNTRY) (Reuters) (press)
  • Arthritis drug Eli Lilly helped Covid-19 hospitalized patients recover faster (WSJ) (press)
  • FDA rejects Mallinckrodt kidney drug on suspicion of risk benefits (Wild) (Final points)
  • The vaccine maker received $ 1 billion from taxpayers. Now it is raising the prices of medicines (LA Times)

In Focus: International

  • WHO chief urges rich nations to join vaccine scheme by Friday (Reuters)
  • Oxford and AstraZeneca resume trial of coronavirus vaccine (FT) (Reuters)
  • Regeneron antibody drug was added to the UK Recovery trial of COVID treatments (Reuters) (BBC)
  • Coronavirus: MB to test for inhaled vaccines (BBC)
  • Russia completes voluntary recruitment for COVID-19 vaccine trial: fund (Reuters)
  • The United Arab Emirates announces emergency approval for the use of the COVID-19 vaccine (Reuters)
  • Roche says two-thirds of Evrysdi patients had received rival treatments (Reuters)
  • Novartis intends to expand Beovu use as security fears undermine launch (Reuters)
  • Canadian Pascal Biosciences partners with SoRSE to test cannabis-based cancer therapy (Reuters)

Coronavirus pandemic

  • Vaccine makers keep security details scientists calm and alert (NYTimes)
  • Covid vaccine not enough for everyone until 2024, says the largest manufacturer (FT)
  • Trump loyalists tried to influence CDC virus reports (NYTimes)
  • Early research by 23andMe strengthens the link between blood types and Covid-19 (COUNTRY)
  • Gilead CEO: We are exploring new ways to treat coronavirus with remdesivir out of hospital (CNBC)
  • As trials of COVID-19 vaccines move at breakneck speed, recruiting black volunteers takes time (NPR)
  • Valneva announces major COVID-19 vaccine partnership with UK government (PMLive)
  • Coronavirus Update (COVID-19): Daily Summary September 11, 2020 (FDA)

Pharma & Biotech

  • Neurocrine initiates Parkinson’s therapy after COVID-19-related disruptions are alleviated (Reuters)
  • Cancer projects to diversify genetic research receive new grants (NYTimes)
  • PIC / S Interprets Checklist for Audit of GMP Drug Inspectorates (Pink leaf)
  • How much is a startup worth? For biotechnology companies, the answer is rarely public (COUNTRY)
  • US FDA Oncology Applications: Real-time display and progress path show consistent appeal (Reuters)
  • ICER criticizes the cost of 8 UC-targeted immune modulators, recommending some deep reductions (Final points)
  • Gilead player CAR-T Kite bids farewell to search chief Peter Emtage while another senior executive hits the exit (Final points)
  • Arie Belldegrun and David Chang godfather launch $ 110 million of a new cell therapy player. And he is also thinking a lot (Final points)
  • Thanks to a $ 77.5 million Serie B, Escient moves to the clinic with its first sensory receptor candidate (Final points)
  • Escape Bio raises $ 73 million as competition with Biogen and Denali with good heels heats up (Final points)
  • The strongest unapproved application of stem cells accompanies the FDA Center for Advances in Cell Biology and Gene Therapy (IPQ)
  • FDA Prescribes Dupixent® (Dupilumab) Progressive Therapy for Eosinophilic Esophagitis (press)
  • Novartis reports positive topline results from the first phase III test of Beovu® versus aflibercept in patients with diabetic macular edema (DME) (press)
  • Novartis data show that early treatment with Mayzent® (siponimod) delays the progression of disability and shows benefits in cognitive performance in patients with progressive multiple sclerosis (SPMS) (press)


  • Abbott, Illumina, other medtechs form guides that convey device risks to patients (MedtechDive)
  • Fitbit will launch the first ECG app in the US, Europe next month (Wild)
  • MHRA Lee will give Medtech Industry in the UK the Greatest Focus on Diagnosis (MedtechInsight)

Government, Regulatory & Legal

  • The Patent Board gives a kick to the University of California over its claims for the CRISPR invention (COUNTRY) (science)
  • A Pennsylvania lawmaker wants to link prescription drug prices to those paid by Canada (COUNTRY)

Regulator Recon is our daily intelligence information on the space of regulatory issues, bringing you the best regulatory news, biofarm and medtech from around the world.

The inclusion of a story in the Recon Regulation does not imply endorsement by the Focus Regulator or RAPS.

What Are The Main Benefits Of Comparing Car Insurance Quotes Online

LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos

picture credit


to request, modification Contact us at Here or [email protected]

Please disable the ad-blocker on this page to see the content